First Time Loading...

PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 0.082 AUD -1.2% Market Closed
Updated: Mar 29, 2024

Wall Street
Price Targets

PYC Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYC is 0.352 AUD with a low forecast of 0.303 AUD and a high forecast of 0.41 AUD.

Lowest
Price Target
0.303 AUD
270% Upside
Average
Price Target
0.352 AUD
329% Upside
Highest
Price Target
0.41 AUD
399% Upside
PYC Therapeutics Ltd Competitors:
Price Targets
4891
TMS Co Ltd
169% Upside
RCUS
Arcus Biosciences Inc
112% Upside
301047
Sino Biological Inc
49% Upside
CYTH
Cyclo Therapeutics Inc
194% Upside
CYTK
Cytokinetics Inc
39% Upside
ARMP
Armata Pharmaceuticals Inc
95% Upside
MGX
Metagenomi Inc
120% Upside
TRML
Tourmaline Bio Inc
120% Upside

Revenue
Forecast

Revenue Estimate
PYC Therapeutics Ltd

For the last 8 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 45%. The projected CAGR for the next 3 years is 1%.

45%
Past Growth
1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
PYC Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
PYC Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PYC's stock price target?
Price Target
0.352 AUD

According to Wall Street analysts, the average 1-year price target for PYC is 0.352 AUD with a low forecast of 0.303 AUD and a high forecast of 0.41 AUD.

What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
1%

For the last 8 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 45%. The projected CAGR for the next 3 years is 1%.